Dr Reddys Laboratories Share Price Today - Live Blog for March 27, 2025

The stock of Dr Reddys Laboratories Ltd is facing a -0.14% decline and is currently trading at ₹1,160.10 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a -0.24% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,160.10. Investors should examine the factors driving this decline. The stock's PE ratio is 18.0800, whereas the industry PE ratio stands at 34.3929.

Dr Reddys Laboratories Ltd's share price has dropped by -0.17%, a development that warrants careful analysis. Presently trading at ₹1,160.10, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd witnessed a -0.03% drop in its share price and is currently trading at ₹1,161.00. With the stock's PE at 18.0800 and the industry PE at 34.3929, investors are weighing their options.

Dr Reddys Laboratories Ltd share price surged by 0.69%. With its current market price standing at ₹1,161.35 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's stock has surged by 0.11%, and it is currently trading at ₹1,154.05. Additionally, the stock maintains a PE ratio of 18.0800, while the industry PE is 34.3929.

Dr Reddys Laboratories Ltd's stock price surged by 0.11%, reaching the current market value of ₹1,154.05 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd observed a remarkable 0.16% surge in its share price and is presently trading at ₹1,156.00. The increased investor interest is driving this surge.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.16%, reaching the current market price of ₹1,156.00. This ascent signifies increased investor sentiment. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.16% increase and currently trading at ₹1,156.00 per share. This upward trajectory is turning heads in the market.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.21%, signalling a challenging period. Currently trading at ₹1,153.85, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd experienced a -0.21% dip in its share price and is currently trading at ₹1,153.85. The stock has a PE ratio of 18.0800, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.11%. At this moment, it's actively trading at ₹1,156.25, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.30% upswing, and it's currently trading at ₹1,154.95 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd share price surged by 0.30%. With its current market price standing at ₹1,154.95 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.07%, and as of now, it's trading at ₹1,151.50 per share. This upward trajectory is attracting keen interest from investors.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.07%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,151.50 per share.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.07% boost, with the current market value at ₹1,151.50 per share. This surge has not gone unnoticed by investors.

After a notable 0.07% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,151.50. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.00% upswing and is currently trading at ₹1,150.85, indicating strong market sentiment.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.00% uptick in its share price. As a result, it's now actively trading at ₹1,150.85 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd observed a remarkable 0.00% surge in its share price and is presently trading at ₹1,150.85. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.00% uptick in its share price. As a result, it's now actively trading at ₹1,150.85 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.00%, reaching the current market price of ₹1,150.85. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd witnessed a substantial 0.15% increase in its share price and is currently trading at ₹1,151.00. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd stock price decreased by -0.08%, with the current market value at ₹1,149.30 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's stock has surged by 0.12%, and it is currently trading at ₹1,150.40. Additionally, the stock maintains a PE ratio of 18.0800, while the industry PE is 34.3929.

Dr Reddys Laboratories Ltd experienced a -0.14% downturn in its share price, and it's currently trading at ₹1,149.10. This situation is generating interest among value investors who are evaluating the stock's potential.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.27% in its share price, and it currently trades at ₹1,148.30 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd's stock price surged by 0.03%, reaching the current market value of ₹1,151.60 per share. This surge is a testament to the stock's recent performance.

With a -0.10% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,151.20. The stock is currently trading at a PE of 18.0800, while the industry PE is 34.3929, prompting investors to assess its value proposition.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.12% drop, and it's now trading at ₹1,151.30 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Demonstrating a commendable 0.54% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,151.95. In terms of valuation, the stock maintains a PE ratio of 18.0800, while the industry PE ratio stands at 34.3929.

After a -0.52% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,144.55. The stock has a PE ratio of 18.0800, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd observed a -0.52% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,144.55. The stock has a PE ratio of 18.0800, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The share price of Dr Reddys Laboratories Ltd remained fixed, with no fluctuations, and is currently at ₹1,172.00. Investors may choose to investigate the factors contributing to this price stability and whether it presents an investment opportunity.

Dr Reddys Laboratories Ltd displayed price stability, with no changes, and is trading at ₹1,172.00. While the stock's performance remains constant, it's worth noting that its PE ratio is 18.0800, while the industry PE is 34.3929.